Original language | English |
---|---|
Article number | e58 |
Journal | HemaSphere |
Volume | 8 |
Issue number | 3 |
Number of pages | 5 |
ISSN | 2572-9241 |
DOIs | |
Publication status | Published - 2024 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Clonal hematopoiesis and COVID-19 hospitalization in Danish adults. / Burgos Sequeros, Celia; Tulstrup, Morten; Bliddal, Sofie; Sørensen, Karina Meden; Nissen, Ioanna; Rezahosseini, Omid; Brooks, Patrick Terrence; Feenstra, Bjarke; Gang, Anne Ortved; Geller, Frank; Hald, Annemette; Harboe, Zitta Barrella; Helleberg, Marie; Jespersen, Jakob S.; Lebech, Anne Mette; Lindegaard, Birgitte; Mogensen, Trine H.; Møller, Maria Elizabeth Engel; Nielsen, Claus Henrik; Niemann, Carsten Utoft; Podlekareva, Daria; Sejdic, Adin; Sørensen, Erik; Teglgaard, Rebecca Svanberg; Tommerup, Niels; Weis, Nina; Brunak, Søren; Pedersen, Ole Birger Vestager; Banasik, Karina; Feldt-Rasmussen, Ulla; Nielsen, Susanne Dam; Ostrowski, Sisse Rye; Grønbæk, Kirsten.
In: HemaSphere, Vol. 8, No. 3, e58, 2024.Research output: Contribution to journal › Letter › Research › peer-review
}
TY - JOUR
T1 - Clonal hematopoiesis and COVID-19 hospitalization in Danish adults
AU - Burgos Sequeros, Celia
AU - Tulstrup, Morten
AU - Bliddal, Sofie
AU - Sørensen, Karina Meden
AU - Nissen, Ioanna
AU - Rezahosseini, Omid
AU - Brooks, Patrick Terrence
AU - Feenstra, Bjarke
AU - Gang, Anne Ortved
AU - Geller, Frank
AU - Hald, Annemette
AU - Harboe, Zitta Barrella
AU - Helleberg, Marie
AU - Jespersen, Jakob S.
AU - Lebech, Anne Mette
AU - Lindegaard, Birgitte
AU - Mogensen, Trine H.
AU - Møller, Maria Elizabeth Engel
AU - Nielsen, Claus Henrik
AU - Niemann, Carsten Utoft
AU - Podlekareva, Daria
AU - Sejdic, Adin
AU - Sørensen, Erik
AU - Teglgaard, Rebecca Svanberg
AU - Tommerup, Niels
AU - Weis, Nina
AU - Brunak, Søren
AU - Pedersen, Ole Birger Vestager
AU - Banasik, Karina
AU - Feldt-Rasmussen, Ulla
AU - Nielsen, Susanne Dam
AU - Ostrowski, Sisse Rye
AU - Grønbæk, Kirsten
N1 - Funding Information: Kirsten Grønbæk has received research funding and/or consultancy fees from Janssen Pharma and GSK. Carsten Utoft Niemann has received research funding and/or consultancy fees from Abbvie, AstraZeneca, Janssen, Octapharma, Beigene, Genmab, CSL Behring, Takeda, Lilly, and MSD. Anne‐Mette Lebech has received unrestricted research grant from Gilead and consultancy fees from GSK, MSD, and Pfizer. Funding Information: This study was supported by a research grant from the European Hematology Association (EHA COVID‐19 in Hematology Research Grant 2020). In addition, the study is part of the Danish Research Center for Precision Medicine in Blood Cancers (Danish Cancer Society Grant R223‐A13071). A grant from Sygesikring Danmark (2020‐0178) was given to the Danish COVID‐19 Genetic Consortium. Celia Burgos Sequeros, Karina Banasik, and Søren Brunak acknowledge the Novo Nordisk Foundation (Grant numbers: NNF17OC0027594 and NNF14CC0001). This work was also supported by a grant from the Ministry of Higher Education and Science, Copenhagen, Denmark (0238‐00006B). This research has been conducted using the Danish National Biobank resource. UFR's research salary was sponsored by Kirsten and Freddy Johansen's Fund.
PY - 2024
Y1 - 2024
U2 - 10.1002/hem3.58
DO - 10.1002/hem3.58
M3 - Letter
C2 - 38463443
AN - SCOPUS:85187448409
VL - 8
JO - HemaSphere
JF - HemaSphere
SN - 2572-9241
IS - 3
M1 - e58
ER -